Does Mounjaro Lower Testosterone Levels?

What the trials actually show about weight loss and testosterone

The starting point for this question is not Mounjaro specifically, but what decades of obesity research tell us about the link between body fat and male hormones. Adipose tissue, particularly visceral fat around the abdomen, converts testosterone into oestrogen through a process called aromatisation. The more excess fat a man carries, the more of this conversion happens, and the lower his circulating testosterone tends to be. This pattern is well documented in the medical literature and underpins why men with obesity disproportionately report symptoms of low testosterone.

When that fat is lost, whether through diet, surgery or medicines, free testosterone typically rises. A systematic review of bariatric surgery outcomes found meaningful increases in total testosterone following significant weight reduction. The SURMOUNT-1 trial, published in the New England Journal of Medicine, recorded average body-weight reductions of around 20–21% at the 15 mg dose of tirzepatide over 72 weeks in adults without diabetes. At that scale of weight loss, the hormonal shift for men with obesity would be expected to move testosterone upward, not down.

Mounjaro's mechanism as a dual GIP and GLP-1 receptor agonist does not include any known direct pathway suppressing testosterone synthesis. The SURMOUNT programme involved thousands of adults, and no signal of testosterone suppression emerged as a safety concern in the published data or in the prescribing information on the electronic Medicines Compendium.

Why some men worry their testosterone has dropped on Mounjaro

It is a fair question. Some men starting tirzepatide report feeling tired, less motivated, or experiencing a dip in libido during the early weeks. These symptoms overlap with low testosterone, which creates understandable concern. In practice, several other explanations are more likely during the initial phase of treatment.

Calorie restriction on its own, if it is severe, can temporarily suppress hormone production. Mounjaro reduces appetite substantially, and men who eat far less than their body needs, particularly protein, may notice fatigue and reduced energy. Getting enough protein each day matters during weight loss with any medicine; NHS guidance on healthy weight consistently emphasises the role of adequate nutrition alongside any weight-management approach.

Nausea and disturbed sleep, both common early side effects, also blunt energy and mood. Separating the cause of fatigue during the first few weeks of treatment is genuinely difficult without blood tests. If the symptoms persist beyond the early adjustment period, a simple testosterone blood panel through your GP takes under a minute to request and gives a concrete answer. That is the most practical step available and worth doing if you are concerned.

Questions about how tirzepatide may interact with hormones more broadly are covered on the does Mounjaro affect testosterone page, including what to discuss with your prescriber if you are already being treated for low testosterone.

Men already on testosterone replacement therapy

If you are currently prescribed testosterone replacement therapy (TRT) and want to start Mounjaro, the key question for your prescriber is how to monitor both treatments together. There is no pharmacological interaction that makes TRT and tirzepatide incompatible, but as body weight falls and natural testosterone production potentially recovers, your existing TRT dose may need to be reviewed. More detail on taking Mounjaro and testosterone together is worth reading before your consultation.

Women sometimes ask a parallel question about progesterone and other hormones during treatment; the Mounjaro and progesterone page addresses that separately. And if cholesterol is also on your radar, Mounjaro's effect on cholesterol levels is a distinct but related area where the evidence is encouraging.

One practical point: significant weight loss over months can shift a number of metabolic markers simultaneously. Keeping a record of how you feel at each monthly review, and sharing that with your prescriber, makes clinical decisions much cleaner than trying to recall how things felt six months ago.

Getting clinically assessed before starting treatment

Mounjaro is a prescription-only medicine. A prescriber needs to review your full health picture before any treatment is approved, including any existing hormonal conditions or therapies. At nume, a GPhC-registered Independent Prescriber reads every consultation personally on the day it is submitted. No algorithm makes the call.

If hormonal health is a concern for you, you can flag it in the consultation and it will be considered alongside everything else. You can find out more about tirzepatide's licensed use and clinical profile, read a broader overview on the Mounjaro treatment page, or look at Mounjaro pricing before you start. Our weight-loss treatment overview sets out how the different options compare. When you are ready, start your free consultation and a prescriber will take it from there.